| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/1998 | EP0815232A1 Protein production and delivery |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815230A2 MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR |
| 01/07/1998 | EP0815229A2 Rage tumor rejection antigens |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |
| 01/07/1998 | EP0815224A1 Receptor activation by gas6 |
| 01/07/1998 | EP0815223A1 Dermatomyositis-specific auto-antigen |
| 01/07/1998 | EP0815222A1 Sperm factor |
| 01/07/1998 | EP0815221A1 A novel growth factor and a genetic sequence encoding same |
| 01/07/1998 | EP0815220A1 Human amine transporter |
| 01/07/1998 | EP0815219A1 Human b-cell translocation genes-2 and 3 |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815217A1 Antisense oligonucleotides for inhibiting helicobacter pylori activity |
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815215A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
| 01/07/1998 | EP0815211A1 New defined enzyme mixtures for obtaining cells and treating wounds |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815199A1 Human deoxycytidine kinase 2 |
| 01/07/1998 | EP0815197A1 Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome |
| 01/07/1998 | EP0815139A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 01/07/1998 | EP0815138A1 Stable polymerized hemoglobin blood-substitute |
| 01/07/1998 | EP0815137A1 Human g-protein chemokine receptor hdgnr10 |
| 01/07/1998 | EP0815136A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/07/1998 | EP0815135A1 Lipophilic peptide hormone derivatives |
| 01/07/1998 | EP0815134A1 Modulators of amyloid aggregation |
| 01/07/1998 | EP0815133A1 Human stat4 |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815130A1 Casein phosphopeptide, casein containing same and process for the preparation thereof |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815128A2 Amphiphilic peptide and analogs thereof |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815125A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES |
| 01/07/1998 | EP0815124A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/07/1998 | EP0815123A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0814846A1 Gene therapy by secretory gland expression |
| 01/07/1998 | EP0814845A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 01/07/1998 | EP0814841A2 Hcg liquid formulations |
| 01/07/1998 | EP0814838A1 Antigen presenting system and methods for activation of t-cells |
| 01/07/1998 | EP0814837A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/07/1998 | EP0814834A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 01/07/1998 | EP0814833A1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
| 01/07/1998 | EP0814832A1 ISOFORMS OF HUMAN INTERLEUKIN-1$g(b) CONVERTING ENZYME AND METHODS OF USING THE SAME |
| 01/07/1998 | EP0814831A1 Method for treatment of autoimmune diseases using interferon-tau |
| 01/07/1998 | EP0814829A1 Method for enhancing the antibody response to specific antigens with interleukin-10 |
| 01/07/1998 | EP0814828A1 Method of preparation a therapeutic agent for the regeneration of oligodendrocytes |
| 01/07/1998 | EP0814827A1 Vascular endothelial growth factor-b |
| 01/07/1998 | EP0814826A1 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814791A1 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 01/07/1998 | EP0814785A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility |
| 01/07/1998 | EP0814778A1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 01/07/1998 | EP0814775A1 Method and kit for preventing erectile dysfunction |
| 01/07/1998 | EP0814774A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0778847A4 Immunostimulatory agents |
| 01/07/1998 | EP0730604A4 Surface membrane proteins and their effect on immune response |
| 01/07/1998 | EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY |
| 01/07/1998 | EP0713527A4 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0682529B1 Antibody for the treatment of insulin dependent diabetes |
| 01/07/1998 | EP0646171A4 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes. |
| 01/07/1998 | EP0592490B1 Amino acid derivative anticonvulsant |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | EP0486572B1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | CN1169778A Detection and treatment of cancer |
| 01/07/1998 | CN1169754A Human interleudin-1 receptor accessory Protein |
| 01/07/1998 | CN1169733A Analogs of keratinocyte growth factor |
| 01/07/1998 | CN1169732A Keratinocyte growth factor analogs |
| 01/07/1998 | CN1169731A Tachykinin antagonists |
| 01/07/1998 | CN1169730A Aromatic heterocyclic derivatives as enzyme inhibitors |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/07/1998 | CN1169317A Blood vessel endothelial factor and antagonist thereof |
| 01/07/1998 | CN1036934C Process for preparing isohirudins with improved stability |
| 01/06/1998 | US5705693 Cationic lipids |
| 01/06/1998 | US5705686 Inhibition of farnesyl transferase |
| 01/06/1998 | US5705626 Polypeptide for aids therapy |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705623 Nucleic acid sequences |
| 01/06/1998 | US5705617 Neurotrophic factors having altered receptor binding specificities |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705614 Methods of producing antigen forks |
| 01/06/1998 | US5705609 Decorin fragments inhibiting cell regulatory factors |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705607 Procedures for the isolation and titration of sarcocystine or parasite toxin of sarcocystis genus |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705488 Injectable compositions for soft tissue augmentation |
| 01/06/1998 | US5705487 Antithrombotic agents |
| 01/06/1998 | US5705486 Anticoagulants for blood disorders |
| 01/06/1998 | US5705485 Gel formulations containing growth factors |
| 01/06/1998 | US5705484 Biologically active polypeptide fusion dimers |
| 01/06/1998 | US5705483 Glucagon-like insulinotropic peptides, compositions and methods |
| 01/06/1998 | US5705482 Human growth hormone and leucine-histidine-leucine tripeptide mixture; storage stability; glandular disorders |
| 01/06/1998 | US5705481 Arginine-containing pentpeptides |
| 01/06/1998 | US5705479 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 01/06/1998 | US5705478 Covalently linked β subunits of the glycoprotein hormones as antagonists |